Lisinopril-hctz 20-25 MG tab 500S
Ended Awarded Last action
- Contract number
- SPE2DR26F5W81
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,819
Award facts
- Contract value 100% obligated
- $2,819.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $2,819.20 by the Defense Logistics Agency (DLA) on January 8, 2026, for the supply of 500 tablets of Lisinopril-HCTZ 20-25 mg. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award based on open competition. Performance will be completed by January 9, 2026, at the vendor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military healthcare programs globally.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor for federal medical procurement, with particular emphasis on supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The parent company, Cencora, Inc., maintains a substantial Indefinite Delivery Contract with DLA valued at up to $999,999,999.00 through December 31, 2031, covering an extensive portfolio of pharmaceutical products, medical supplies, specialty medications, vaccines, and related medical commodities. The delivery of Lisinopril-HCTZ, an antihypertensive combination medication, exemplifies the routine pharmaceutical supply operations that AmerisourceBergen executes under its federal contract vehicles to support military treatment facilities and other government healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26F5W81?
SPE2DR26F5W81 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F5W81 worth?
The government has obligated $2,819 on SPE2DR26F5W81.
Is contract SPE2DR26F5W81 an order under another contract?
Yes. SPE2DR26F5W81 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5W81 competed?
The extent of competition for SPE2DR26F5W81 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award